WILLIAM MARSHALL: Open Payments
NPI 1063448009 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 26 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $604
Food & beverage: $532Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $155 |
| PFIZER INC. | 4 | $82 |
| ABBVIE INC. | 4 | $77 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
| UCB, Inc. | 2 | $60 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $27 |
| Incyte Corporation | 1 | $26 |
| Botanix SB Inc | 1 | $21 |
| Organogenesis Inc. | 1 | $21 |
Products named: TREMFYA, CIBINQO, DUPIXENT, Bimzelx, RINVOQ, COSENTYX, ILUMYA, OPZELURA.
Industry payments across GA — which companies pay providers there.
